FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896700811> ?p ?o ?g. }

• W2896700811 endingPage "e024882" @default.
• W2896700811 startingPage "e024882" @default.
• W2896700811 abstract "Introduction Idiopathic nephrotic syndrome is the most common glomerular disease in childhood with an incidence of 1.8 cases per 100 000 children in Germany. The treatment of the first episode implies two aspects: induction of remission and sustainment of remission. The recent Kidney Disease Improving Global Outcomes, American Academy of Pediatrics and German guidelines for the initial treatment of the first episode of a nephrotic syndrome recommend a 12-week course of prednisone. Despite being effective, this treatment is associated with pronounced glucocorticoid-associated toxicity due to high-dose prednisone administration over a prolonged period of time. The aim of the INTENT study (Initial treatment of steroid-sensitive idiopathic nephrotic syndrom in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial) is to show that an alternative treatment regimen with mycophenolic acid is not inferior regarding sustainment of remission, but with lower toxicity compared with treatment with glucocorticoids only. Methods and design The study is designed as an open, randomised, controlled, multicentre trial. 340 children with a first episode of steroid-sensitive nephrotic syndrome and who achieved remission by a standard prednisone regimen will be enrolled in the trial and randomised to one of two treatment arms. The standard care group will be treated with prednisone for a total of 12 weeks; in the experimental group the treatment is switched to mycophenolate mofetil, also for a total of 12 weeks in treatment duration. The primary endpoint is the occurrence of a treated relapse within 24 months after completion of initial treatment. Ethics and dissemination Ethics approval for this trial was granted by the ethics committee of the Medical Faculty of the University of Heidelberg (AFmu-554/2014). The study results will be published in accordance with the Consolidated Standards of Reporting Trials statement and the Standard Protocol Items: Recommendations for Interventional Trials guidelines. Our findings will be submitted to major international paediatric nephrology and general paediatric conferences and submitted for publication in a peer-reviewed, open-access journal. Trial registration number DRKS0006547; EudraCT2014-001991-76; Pre-result. Date of registration 30 October 2014; 24 February 2017." @default.
• W2896700811 created "2018-10-26" @default.
• W2896700811 creator A5001827335 @default.
• W2896700811 creator A5006521153 @default.
• W2896700811 creator A5017241443 @default.
• W2896700811 creator A5017679143 @default.
• W2896700811 creator A5027620181 @default.
• W2896700811 creator A5028520248 @default.
• W2896700811 creator A5035714867 @default.
• W2896700811 creator A5044136682 @default.
• W2896700811 creator A5048588130 @default.
• W2896700811 creator A5048758841 @default.
• W2896700811 creator A5080152645 @default.
• W2896700811 creator A5082203166 @default.
• W2896700811 creator A5083438359 @default.
• W2896700811 creator A5086021542 @default.
• W2896700811 creator A5087488667 @default.
• W2896700811 creator A5089804308 @default.
• W2896700811 date "2018-10-01" @default.
• W2896700811 modified "2023-09-30" @default.
• W2896700811 title "Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil<i>versus</i>prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study)" @default.
• W2896700811 cites W123835664 @default.
• W2896700811 cites W1980836240 @default.
• W2896700811 cites W2005367998 @default.
• W2896700811 cites W2005554822 @default.
• W2896700811 cites W2021500689 @default.
• W2896700811 cites W2028829857 @default.
• W2896700811 cites W2034118721 @default.
• W2896700811 cites W2047135575 @default.
• W2896700811 cites W2074623848 @default.
• W2896700811 cites W2077128033 @default.
• W2896700811 cites W2084620309 @default.
• W2896700811 cites W2093007274 @default.
• W2896700811 cites W2097744101 @default.
• W2896700811 cites W2108455316 @default.
• W2896700811 cites W2145601642 @default.
• W2896700811 cites W2160430974 @default.
• W2896700811 cites W2168584903 @default.
• W2896700811 cites W2169596284 @default.
• W2896700811 cites W2171767062 @default.
• W2896700811 cites W2416683641 @default.
• W2896700811 cites W4300767941 @default.
• W2896700811 cites W4360754741 @default.
• W2896700811 doi "https://doi.org/10.1136/bmjopen-2018-024882" @default.
• W2896700811 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6252704" @default.
• W2896700811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30309995" @default.
• W2896700811 hasPublicationYear "2018" @default.
• W2896700811 type Work @default.
• W2896700811 sameAs 2896700811 @default.
• W2896700811 citedByCount "16" @default.
• W2896700811 countsByYear W28967008112019 @default.
• W2896700811 countsByYear W28967008112020 @default.
• W2896700811 countsByYear W28967008112021 @default.
• W2896700811 countsByYear W28967008112022 @default.
• W2896700811 countsByYear W28967008112023 @default.
• W2896700811 crossrefType "journal-article" @default.
• W2896700811 hasAuthorship W2896700811A5001827335 @default.
• W2896700811 hasAuthorship W2896700811A5006521153 @default.
• W2896700811 hasAuthorship W2896700811A5017241443 @default.
• W2896700811 hasAuthorship W2896700811A5017679143 @default.
• W2896700811 hasAuthorship W2896700811A5027620181 @default.
• W2896700811 hasAuthorship W2896700811A5028520248 @default.
• W2896700811 hasAuthorship W2896700811A5035714867 @default.
• W2896700811 hasAuthorship W2896700811A5044136682 @default.
• W2896700811 hasAuthorship W2896700811A5048588130 @default.
• W2896700811 hasAuthorship W2896700811A5048758841 @default.
• W2896700811 hasAuthorship W2896700811A5080152645 @default.
• W2896700811 hasAuthorship W2896700811A5082203166 @default.
• W2896700811 hasAuthorship W2896700811A5083438359 @default.
• W2896700811 hasAuthorship W2896700811A5086021542 @default.
• W2896700811 hasAuthorship W2896700811A5087488667 @default.
• W2896700811 hasAuthorship W2896700811A5089804308 @default.
• W2896700811 hasBestOaLocation W28967008111 @default.
• W2896700811 hasConcept C126322002 @default.
• W2896700811 hasConcept C141071460 @default.
• W2896700811 hasConcept C168563851 @default.
• W2896700811 hasConcept C187212893 @default.
• W2896700811 hasConcept C203092338 @default.
• W2896700811 hasConcept C2777747828 @default.
• W2896700811 hasConcept C2778033501 @default.
• W2896700811 hasConcept C2778415529 @default.
• W2896700811 hasConcept C2778720950 @default.
• W2896700811 hasConcept C2778930706 @default.
• W2896700811 hasConcept C2780091579 @default.
• W2896700811 hasConcept C2780368995 @default.
• W2896700811 hasConcept C2781413609 @default.
• W2896700811 hasConcept C2909935303 @default.
• W2896700811 hasConcept C2911091166 @default.
• W2896700811 hasConcept C71924100 @default.
• W2896700811 hasConceptScore W2896700811C126322002 @default.
• W2896700811 hasConceptScore W2896700811C141071460 @default.
• W2896700811 hasConceptScore W2896700811C168563851 @default.
• W2896700811 hasConceptScore W2896700811C187212893 @default.
• W2896700811 hasConceptScore W2896700811C203092338 @default.
• W2896700811 hasConceptScore W2896700811C2777747828 @default.
• W2896700811 hasConceptScore W2896700811C2778033501 @default.
• W2896700811 hasConceptScore W2896700811C2778415529 @default.
• W2896700811 hasConceptScore W2896700811C2778720950 @default.

• next